A new study published in Lancet Gastroenterology and Hepatology has shown that orally administered faecal microbiota transplantation (FMT) could lead to the remission of ulcerative colitis, with one of the researchers heading the trial now outlining the...
Gold kiwi fruit supplementation increases the abundance of bacteria associated with a lower risk of gastrointestinal disorders, leading researchers to conclude it offers a potential strategy for improving gut microbiota composition.
Nestlé Health Science has made its third significant investment of the year by buying an 18% stake in a 20-year-old New Zealand start-up that specialises in kiwi fruit extract products with digestive health benefits.
The new Health Science division Nestlé created last September has made its second acquisition by buying $250m a year US gastroenterology and oncology diagnostic specialist, Prometheus Laboratories Inc., for an undisclosed sum.
Daily supplements of a blend of the bacterial strains Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 (Probio-Tec AB-25) was no better than placebo for maintaining remission of ulcerative colitis.
Nestlé Health Science, the division the food giant created in September last year to research and develop medical and functional foods, has bought UK medical foods start-up CM&D Pharma Limited, with more acquisitions – both small and large – set to...
Nutraceutical developer Provexis says it is in advanced discussions
over exiting its demonstration juice brand Sirco to focus on the
future, as it reports strong sales and a reduction in its operating
loss in the full year ended March...
Children and adolescents with inflammatory bowel disease (IBD) are
at an increased risk of vitamin D deficiency and could benefit from
supplements to avoid the health problems associated with not
getting enough of the vitamin.
Advitech's global roll out plan for its psoriasis nutraceutical
Dermylex is coming together, with definitive agreements in Canada
and France, interim financing, and new appointments as it moves
into the implementation phase.
Nutraceutical developer Provexis has entered into a collaboration
agreement with an unnamed 'leading' clinical nutrition company to
create a food containing its plantain extract for people with
inflammatory bowel diseases.
A UK nutraceutical firm is hoping to develop an extract of the
plaintain banana as a medical food, after initial research shows it
could treat inflammatory bowel disease, such as Crohn's disease,
writes Dominique Patton.